8-K: Boston Scientific Director Charles J. Dockendorff to Depart Board at 2025 Annual Meeting

Charles J. Dockendorff will not seek re-election to Boston Scientific's Board of Directors at the 2025 Annual Meeting.

Summary

• Charles J. Dockendorff has informed Boston Scientific Corporation that he will not stand for re-election at the company's 2025 Annual Meeting of Stockholders.
• Mr. Dockendorff has been a member of the Board of Directors since April 2015 and currently serves on the Audit Committee and the Risk Committee.
• He will continue to serve in his current roles until the 2025 Annual Meeting.
• Mr. Dockendorff's decision is not due to any disagreement with the company.
• The Board and Nominating and Governance Committee will assess whether to add new directors following his departure.

Sentiment

Score: 7

Explanation: The announcement is neutral to slightly positive. The departure is not due to disagreements, and the company is proactively managing the transition.

Positives

• The company states that Mr. Dockendorff's decision is not the result of any disagreement with Boston Scientific, suggesting a smooth transition.
• The Board and Nominating and Governance Committee are actively reviewing the Board's composition, indicating proactive management of Board changes.

Risks

• The departure of a long-standing board member like Mr. Dockendorff could potentially disrupt board dynamics.
• There is uncertainty regarding whether the company will appoint a new director to fill the vacancy, which could impact the Board's expertise and decision-making capabilities.

Future Outlook

The Board and Nominating and Governance Committee will evaluate whether adding directors to the Board following Mr. Dockendorff's departure is in the best interest of the Company.

Management Comments

• Charles J. Dockendorff informed Boston Scientific Corporation that he will not stand for re-election at the company's 2025 Annual Meeting of Stockholders.
• Mr. Dockendorff's decision not to stand for re-election at the 2025 Annual Meeting is not the result of any disagreement with the Company.

Industry Context

Board member departures are a common occurrence in publicly traded companies, often triggering a review of board composition and potential recruitment of new directors with specific expertise or perspectives.

Management Changes

Stakeholder Impact

• Shareholders may be interested in the Board's decision regarding the appointment of a new director.
• Employees may experience a slight shift in leadership dynamics at the Board level.

Next Steps

• The Board and Nominating and Governance Committee will evaluate whether to add new directors to the Board.
• The company will hold its 2025 Annual Meeting of Stockholders.

Key Dates